The benefit seems durable, but one expert says patients should be aware there’s “some risk of stroke” during the procedure.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

The US Food and Drug Administration has approved new labeling for two mRNA COVID-19 vaccines (Comirnaty; Pfizer and Spikevax; Moderna) that emphasizes the risk of myocarditis and pericarditis. The ...

NEW YORK, NY—Transcatheter tricuspid valve replacement (TTVR) is safe and effective in patients who have severe tricuspid regurgitation (TR) and preexisting leads from implanted cardiac devices, but ...

Every month, Section Editor L.A. McKeown curates a roundup of recent news beyond our regular TCTMD coverage, with tidbits from journals and medical meetings around the globe that are of special ...

Dimitrios Karmpaliotis, MD, PhD (Morristown Medical Center, NJ), an interventional cardiologist known for his expertise in the field of complex PCI, died suddenly at home yesterday at age 53. News of ...

The US Food and Drug Administration approved a triple therapy polypill for the treatment of patients with hypertension, manufacturer George Medicines announced yesterday. The single pill (Widaplik), ...

Approximately one in nine patients develop leaflet thrombosis in the first 10 months after transcatheter tricuspid valve replacement (TTVR), according to a meta-analysis. Most cases are subclinical, ...

Long-term maintenance with P2Y12 inhibitor monotherapy after discontinuing dual antiplatelet therapy (DAPT) in patients who’ve undergone PCI seems to reduce MACCE compared with aspirin monotherapy ...